Zenarestat

Overview

Zenarestat is a potent and orally active aldose reductase inhibitor. Zenarestat improves diabetic peripheral neuropathy in Zucker diabetic fatty rats.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Aldose Reductase

Product Information

• Catalog No.: HY-116239
• CAS No.: 112733-06-9
• Molecular Formula: C17H11BrClFN2O4
• Molecular Weight: 441.64
• Purity: 99.35%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 25 mg/mL (56.61 mM); Clear solution
• Availability: In-stock

Source

Original product source